adalimumab,upadacitinib
abbvie
['adalimumab', 'upadacitinib']
congress #acr22 | presented a poster on efficacy of upadacitinib and adalimumab on rapid3 scores. patients treated with upadacitinib had a greater improvement in rapid3 scores, compared to patients treated with adalimumab. 
The Psoriasis and Psoriatic Arthritis Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education.